These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
74 related articles for article (PubMed ID: 15937956)
1. Epigenetic inactivation of CHFR in nasopharyngeal carcinoma through promoter methylation. Cheung HW; Ching YP; Nicholls JM; Ling MT; Wong YC; Hui N; Cheung A; Tsao SW; Wang Q; Yeun PW; Lo KW; Jin DY; Wang X Mol Carcinog; 2005 Aug; 43(4):237-45. PubMed ID: 15937956 [TBL] [Abstract][Full Text] [Related]
2. The new 6q27 tumor suppressor DACT2, frequently silenced by CpG methylation, sensitizes nasopharyngeal cancer cells to paclitaxel and 5-FU toxicity via β-catenin/Cdc25c signaling and G2/M arrest. Zhang Y; Fan J; Fan Y; Li L; He X; Xiang Q; Mu J; Zhou D; Sun X; Yang Y; Ren G; Tao Q; Xiang T Clin Epigenetics; 2018 Feb; 10(1):26. PubMed ID: 30359298 [TBL] [Abstract][Full Text] [Related]
3. CHFR: a key checkpoint component implicated in a wide range of cancers. Sanbhnani S; Yeong FM Cell Mol Life Sci; 2012 May; 69(10):1669-87. PubMed ID: 22159584 [TBL] [Abstract][Full Text] [Related]
4. Integrin α9 gene promoter is hypermethylated and downregulated in nasopharyngeal carcinoma. Nawaz I; Hu LF; Du ZM; Moumad K; Ignatyev I; Pavlova TV; Kashuba V; Almgren M; Zabarovsky ER; Ernberg I Oncotarget; 2015 Oct; 6(31):31493-507. PubMed ID: 26372814 [TBL] [Abstract][Full Text] [Related]
5. Association of CHFR Promoter Methylation with Treatment Outcomes of Irinotecan-Based Chemotherapy in Metastatic Colorectal Cancer. Cha Y; Kim SY; Yeo HY; Baek JY; Choi MK; Jung KH; Dong SM; Chang HJ Neoplasia; 2019 Jan; 21(1):146-155. PubMed ID: 30562637 [TBL] [Abstract][Full Text] [Related]
6. Human papillomavirus-positivity is associated with EREG down-regulation and promoter hypermethylation in head and neck squamous cell carcinoma. Khanal S; Strickley JD; Ha T; Demehri S; Ghim SJ; Jenson AB; Redman RA; Joh JJ Exp Mol Pathol; 2020 Dec; 117():104549. PubMed ID: 33007298 [TBL] [Abstract][Full Text] [Related]
7. Epigenetic disruption of cell signaling in nasopharyngeal carcinoma. Li LL; Shu XS; Wang ZH; Cao Y; Tao Q Chin J Cancer; 2011 Apr; 30(4):231-9. PubMed ID: 21439244 [TBL] [Abstract][Full Text] [Related]
8. Promoter Methylation Down-regulates B-cell Translocation Gene 1 Expression in Breast Carcinoma. Woo HY; DO SI; Kim SH; Song SY; Kim HS Anticancer Res; 2019 Oct; 39(10):5361-5367. PubMed ID: 31570430 [TBL] [Abstract][Full Text] [Related]
9. CHFR promotes metastasis of human gastric carcinoma by activating AKT and ERK via NRF2- ROS axis. He F; Ye B; Wu X; Pan J; Wang J; Wang X BMC Gastroenterol; 2023 Apr; 23(1):114. PubMed ID: 37024798 [TBL] [Abstract][Full Text] [Related]
10. Aberrant promoter methylation reduced the expression of protocadherin 17 in nasopharyngeal cancer. Yang S; Dai Z; Li W; Wang R; Huang D Biochem Cell Biol; 2019 Aug; 97(4):364-368. PubMed ID: 30165032 [TBL] [Abstract][Full Text] [Related]
11. CHFR-Promoter-Methylation Status Is Predictive of Response to Irinotecan-based Systemic Chemotherapy in Advanced Colorectal Cancer. Hagiwara T; Sugimoto K; Momose H; Irie T; Honjo K; Okazawa YU; Kawai M; Kawano S; Munakata S; Takahashi M; Kojima Y; Serizawa N; Nagahara A; Hoffman RM; Brock MV; Sakamoto K Anticancer Res; 2022 Feb; 42(2):697-707. PubMed ID: 35093868 [TBL] [Abstract][Full Text] [Related]
12. CHFR Promoter Hypermethylation Is Associated with Gastric Cancer and Plays a Protective Role in Gastric Cancer Process. Dai D; Zhou B; Xu W; Jin H; Wang X J Cancer; 2019; 10(4):949-956. PubMed ID: 30854101 [No Abstract] [Full Text] [Related]
13. Effects of DACT1 methylation status on invasion and metastasis of nasopharyngeal carcinoma. Yang JH; Lin LK; Zhang S Biol Res; 2019 Jun; 52(1):31. PubMed ID: 31182157 [TBL] [Abstract][Full Text] [Related]
14. Epigenetic inactivation of the 5-methylcytosine RNA methyltransferase NSUN7 is associated with clinical outcome and therapeutic vulnerability in liver cancer. Ortiz-Barahona V; Soler M; Davalos V; García-Prieto CA; Janin M; Setien F; Fernández-Rebollo I; Bech-Serra JJ; De La Torre C; Guil S; Villanueva A; Zhang PH; Yang L; Guarnacci M; Schumann U; Preiss T; Balaseviciute U; Montal R; Llovet JM; Esteller M Mol Cancer; 2023 May; 22(1):83. PubMed ID: 37173708 [TBL] [Abstract][Full Text] [Related]
15. The hypermethylation of the Mei X; Cheng M; Chen W; Wu X; Xie M Transl Cancer Res; 2019 Jun; 8(3):770-778. PubMed ID: 35116815 [TBL] [Abstract][Full Text] [Related]
16. Analysis of the methylation of CpG islands in the Maekawa H; Ito T; Orita H; Kushida T; Sakurada M; Sato K; Hulbert A; Brock MV Oncol Lett; 2020 Mar; 19(3):2197-2204. PubMed ID: 32194717 [TBL] [Abstract][Full Text] [Related]
17. Silencing of CHFR Sensitizes Gastric Carcinoma to PARP Inhibitor Treatment. Li Y; Shi Y; Wang X; Yu X; Wu C; Ding S Transl Oncol; 2020 Jan; 13(1):113-121. PubMed ID: 31812083 [TBL] [Abstract][Full Text] [Related]
18. Protocadherin 17 is a tumor suppressor and is frequently methylated in nasopharyngeal carcinoma. He Y; Wang Z; Liu C; Gong Z; Li Y; Lu T; Hu G Cancer Manag Res; 2019; 11():1601-1613. PubMed ID: 30863170 [TBL] [Abstract][Full Text] [Related]
19. Downregulation of SLC27A6 by DNA Hypermethylation Promotes Proliferation but Suppresses Metastasis of Nasopharyngeal Carcinoma Through Modulating Lipid Metabolism. Zhong X; Yang Y; Li B; Liang P; Huang Y; Zheng Q; Wang Y; Xiao X; Mo Y; Zhang Z; Zhou X; Huang G; Zhao W Front Oncol; 2021; 11():780410. PubMed ID: 35047398 [TBL] [Abstract][Full Text] [Related]
20. Blood-based DNA methylation in advanced Nasopharyngeal Carcinoma exhibited distinct CpG methylation signature. Chatterjee K; Mal S; Ghosh M; Chattopadhyay NR; Roy SD; Chakraborty K; Mukherjee S; Aier M; Choudhuri T Sci Rep; 2023 Dec; 13(1):22086. PubMed ID: 38086861 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]